Position in FATE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,715,807
+$495,895 QoQ
Shares Held
2,263,173
-0.1% QoQ
Ownership
1.94%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 24.223247626230958.ToString("F0")%
Shared 0.ToString("F0")%
None 75.77675237376904.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. FATE ranks #225 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in FATE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,715,807 | 2,263,173 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,219,912 | 2,265,217 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,045,590 | 2,417,135 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,496,615 | 2,229,121 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,666,951 | 2,110,065 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,675,036 | 2,227,295 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $18,385,409 | 5,252,974 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,510,899 | 5,338,689 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $58,989,150 | 8,036,669 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,963,577 | 1,861,919 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,816,481 | 2,271,925 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $49,094,216 | 10,313,911 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $84,531,478 | 14,830,084 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $59,888,781 | 5,935,459 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $98,214,827 | 4,382,634 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $130,593,945 | 5,270,135 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $134,626,188 | 3,472,432 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $159,076,578 | 2,718,793 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $141,153,816 | 2,381,539 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $178,314,047 | 2,054,546 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $163,514,510 | 1,983,196 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $191,623,426 | 2,107,373 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $115,997,256 | 2,902,108 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $106,417,302 | 3,101,641 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $54,759,621 | 2,465,539 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||